Valuation: IRADIMED CORPORATION

Market Cap 1.2B 1.05B 971M 909M 1.7B 113B 1.74B 11.67B 4.51B 56B 4.51B 4.41B 194B P/E 2026 *
49.2x
P/E 2027 * 43.4x
Enterprise Value 1.2B 1.05B 971M 909M 1.7B 113B 1.74B 11.67B 4.51B 56B 4.51B 4.41B 194B EV / Sales 2026 *
13.2x
EV / Sales 2027 * 11.9x
Free-Float
64.8%
Yield 2026 *
-
Yield 2027 * -
1 day+0.22%
1 week+2.56%
Current month+3.72%
1 month+3.72%
3 months-0.96%
6 months-3.79%
Current year-3.34%
1 week 91.18
Extreme 91.18
96
1 month 87.91
Extreme 87.91
98.41
Current year 76.95
Extreme 76.95
107.9
1 year 55.11
Extreme 55.1093
107.9
3 years 36.12
Extreme 36.12
107.9
5 years 26
Extreme 26
107.9
10 years 7.85
Extreme 7.85
107.9
Manager TitleAgeSince
Chief Executive Officer 72 28/05/2020
Director of Finance/CFO 64 20/06/2022
Chief Tech/Sci/R&D Officer - 01/01/2020
Director TitleAgeSince
Director/Board Member 73 01/01/2014
Director/Board Member 61 02/09/2025
Director/Board Member 70 01/01/2019
Date Insider Type Main position Quantity % Market Cap.
06-20Fiscal year

Chief Financial Officer

13,911 0.1088%
06-04Sell

Director

-3,000 0.0235%
06-01Sell

Chief Executive Officer

-2,500 0.0196%
Change 5-day change 1-year change 3-year change Capi.($)
+0.31%+2.56%+57.28%+93.29% 1.2B
-3.22%-5.07%-23.38%-27.60% 11.84B
-6.66%-12.39%+66.20%+5.52% 4.59B
-4.01%-5.67%-39.23%-66.93% 1.14B
-3.99%-11.87%-41.79%-51.11% 1.04B
-3.49%-7.80%-44.75% - 871M
-3.51%-14.31%+151.08%+155.61% 600M
+0.80%+15.35% - - 376M
+3.15%+8.94%-56.93%+229.20% 255M
-3.74%-4.36%+98.03%-35.81% 146M
Average -2.44%-3.30%+18.50%+37.77% 2.21B
Weighted average by Cap. -3.71%-5.03%+2.74%-8.28%

Financials

2026 *2027 *
Net sales 91.2M 79.96M 73.71M 69.01M 129M 8.6B 132M 886M 343M 4.25B 342M 335M 14.74B 101M 88.47M 81.55M 76.35M 143M 9.52B 146M 980M 379M 4.7B 379M 371M 16.31B
Net income 24.55M 21.53M 19.84M 18.58M 34.83M 2.32B 35.56M 238M 92.28M 1.14B 92.19M 90.17M 3.97B 27.8M 24.38M 22.47M 21.03M 39.44M 2.62B 40.26M 270M 104M 1.3B 104M 102M 4.49B
Net Debt - -
Logo IRADIMED CORPORATION
IRadimed Corporation develops, manufactures, markets and distributes magnetic resonance imaging (MRI) compatible medical devices and accessories, disposables and services. Its MRidium 3870 MRI Compatible IV infusion pump system provides a non-magnetic Intravenous (IV) infusion pump system that is specifically designed for safe use during MRI procedures. Its MRidium 3860+ MRI Compatible IV infusion pump system has been designed with a non-magnetic ultrasonic motor with non-ferrous parts and other special features to safely and predictably and other IV fluids during various MRI procedures. Its IRadimed 3880 MRI Compatible patient vital signs monitoring system has been designed with non-magnetic components and other features to safely and accurately during various MRI procedures. The Company sells its products primarily to hospitals and acute care facilities. The IRADIMED 3880 system operates dependably on magnetic fields of over 30,000 gauss.
Employees
166
Date Price Change Volume
29/06/26 $94.04 +0.08% 31,442
26/06/26 $93.96 +0.10% 322,740
25/06/26 $93.87 -0.83% 98,588
24/06/26 $94.66 +2.49% 109,511
23/06/26 $92.36 +0.73% 148,140
Trader
Investor
-
Global
-
Quality
-
ESG MSCI
B
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
2
Last Close Price
93.96USD
Average target price
118.00USD
Spread / Average Target
+25.59%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. IRMD Stock